Fluorouracil
Showing 1 - 25 of 2,874
Vitiligo, Topical Fluorouracil, Effervescent Mixture Trial in Cairo (a new effervescent mixture 5-florouracil formula,
Not yet recruiting
- Vitiligo
- +2 more
- a new effervescent mixture 5-florouracil formula
- 5-Fluorouracil plain powder
-
Cairo, EgyptFacualty of Pharmacy, Al Azhar University
Sep 12, 2022
CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))
Not yet recruiting
- CIN 2/3
- HIV Infections
- Intravaginal 5-Fluorouracil (5-FU)
-
Lilongwe, MalawiUNC Project, Kamuzu Central Hospital
Jan 17, 2023
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023
Carcinoma, Squamous Cell Trial in Pittsburgh (5-fluorouracil, Imiquimod 5% cream)
Recruiting
- Carcinoma, Squamous Cell
- 5-fluorouracil
- Imiquimod 5% cream
-
Pittsburgh, PennsylvaniaSt. Margaret Hospital Dermatology
Oct 6, 2022
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022
Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Neoadjuvent
- +3 more
- Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
-
Xi'an, Shaanxi, China
- +2 more
Aug 17, 2023
Oral Leukoplakia Trial in San Francisco (5-fluorouracil)
Not yet recruiting
- Oral Leukoplakia
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in
Not yet recruiting
- Pancreatic Adenocarcinoma Metastatic
-
Pessac, FranceCHU Bordeaux
Aug 17, 2023
The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,
Recruiting
- The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
- Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
-
Hanzhou, Zhejiang, ChinaLulu Liu
Jul 14, 2023
Vitiligo Trial in Qina (Latanoprost 0.005% Ophthalmic Solution, 5Fluorouracil)
Active, not recruiting
- Vitiligo
- Latanoprost 0.005% Ophthalmic Solution
- 5Fluorouracil
-
Qinā, Qena Governorate, EgyptSouth Valley University
Aug 22, 2022
Actinic Keratosis, Organ or Tissue Transplant; Complications Trial in Cleveland (5-Fluorouracil)
Terminated
- Actinic Keratosis
- Organ or Tissue Transplant; Complications
-
Cleveland, OhioCleveland Clinic
Mar 5, 2022
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
Actinic Keratoses Trial in United States (Test Product (A): Fluorouracil Cream, 5% topical cream, Reference Product (B):
Recruiting
- Actinic Keratoses
- Test Product (A): Fluorouracil Cream, 5% topical cream
- +2 more
-
Bakersfield, California
- +6 more
Apr 22, 2022
Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Tislelizumab
- +3 more
- (no location specified)
May 7, 2023
Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- LY01015
- +3 more
- (no location specified)
Aug 28, 2023
Microvascular Function in Patients Undergoing 5-Fluorouracil
Recruiting
- Gastrointestinal Cancer
- +4 more
- Arterial blood pressure
- +3 more
-
Manhattan, KansasLafene Health Center
Mar 30, 2022
Scar Keloid Trial in Dharan Bazar (5-Fluorouracil)
Completed
- Scar Keloid
-
Dharān Bāzār, Province No. 1, NepalB.P. Koirala Institute of Health Sciences
Mar 30, 2022
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Keloid Scar Trial in New York (Fractional erbium:YAG-assisted drug delivery of 5-fluorouracil, Fractional erbium:YAG-assisted
Recruiting
- Keloid Scar
- Fractional erbium:YAG-assisted drug delivery of 5-fluorouracil
- Fractional erbium:YAG-assisted drug delivery of triamcinolone acetonide
-
New York, New YorkNYU Langone Health
Feb 7, 2022
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial
Active, not recruiting
- Cervical Intraepithelial Neoplasia Grade 2/3
- +3 more
- Imiquimod
- Topical Fluorouracil
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jan 28, 2022